CFTR and cancer: The development of a very EO-CRC can be explained by the adverse circumstance of the co-occurrence of CFTR mutations and IC2 LoM, likely responsible for cancer initiation and further triggered by somatic events enhancing the WNT/beta-catenin pathway.